SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Jul 16, 2020
Document Date
May 11, 2020
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe